Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator.
Steinhubl
S R
SR
Moore
S A
SA
Lincoff
A M
AM
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000302:isolation & purification*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D002315:Cardiopulmonary Bypass; D001026:Coronary Artery Bypass / Q000009:adverse effects; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000302:isolation & purification*; D010975:Platelet Aggregation Inhibitors / Q000302:isolation & purification*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D019106:Postoperative Hemorrhage / Q000097:blood / Q000139:chemically induced / Q000517:prevention & control
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab